2024 International Congress Archives - Page 74 of 181

Pain types in multiple system atrophy: results from a community-based survey

N. Campese, G. Göbel, L. Kaltenbach, J. Wanschitz, A. Schlager, B. Caliò, F. Leys, P. Bower, L. Kellermann, L. Zamarian, K. Bannister, R. Chauhuri, A. Schrag, R. Freeman, H. Kaufmann, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)
Palliative and end-of-life care in Parkinson’s disease : French patients’ perceptions and knowledge

M. Auffret, L. Cronier, G. Robert, M. Béreau, M. Giffard, M. Vérin (Rennes, France)
Palliative Care in Advanced Parkinson’s Disease: Descriptive Analysis and Symptom Impact

C. Armengol-García, J. Hartmann-Nava, D. Martínez-Ramírez (Monterrey, Mexico)
Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson’s Disease: Case Study

R. Pessoa, L. Cidral, E. de Souza, M. Marchiori (Curitiba, Brazil)
paraneoplastic cerebellar ataxia: a rare cause of late-onset ataxia

H. Boussaid, R. Zouari, D. Ben Mohamed, A. Rachdi, Z. Said, F. Nebli, S. Ben Sassi (monastir, Tunisia)
Paraneoplastic neurological syndrome mimicking a progressive supranuclear palsy: a case series

R. Zouari, F. Nabli, A. Rachdi, D. Ben Mohamed, MZ. Saeid, S. Ben Sassi (Tunis, Tunisia)
PARKIN gene replacement by AAV-mediated gene delivery as a therapeutic modality for PARKIN-deficient early-onset familial Parkinson’s disease

N. Gattone, AJ. Gilsrud, S. Basu, T. Demarest, B. Wicks, E. Kostuk, D. Narendra, MG. Biferi, E. Ramsburg (Philadelphia, USA)
Parkin regulates ER-mitochondria association through interaction with IP3R-Grp75-VDAC1

NJ. Xue, Y. Liu, ZH. Lin, BR. Zhang, JL. Pu (Hangzhou, China)
Parkinson Disease. An innovative Aproach

M. Martinovic, G. Montado, R. Aljanati (Montevideo, Uruguay)
Parkinson Patients` Motor and Cognitive Functions are Improved by High Intensity LSVT®BIG Physiotherapy – a Randomized Prospective Pilot Trial

B. Wimmer, B. Budeus, M. Katzer, C. Preiner, T. Wächter, K. Seppi, U. Bogdahn (Innsbruck, Austria)
Parkinson’s Disease-Related Pattern in isolated REM Sleep Behavior Disorder as a prodromal progression marker

G. Carli, S. Meles, A. Dortmond, A. Janzen, E. Sittig, E. de Meyer, K. Leenders, W. Oertel (Groningen, Netherlands)
Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)
Parkinson’s Disease (PD) and predictors of Driving Cessation: Results from a 6-year Longitudinal Study and a systematic review of the literature

P. Stamatelos, P. Hatzaki, I. Beratis, D. Pavlou, N. Andronas, E. Stanitsa, S. Fragkiadaki, D. Kontaxopoulou, A. Bonakis, A. Economou, G. Yannis, L. Stefanis, S. Papageorgiou (Athens, Greece)
Parkinson’s disease and Myasthenia Gravis: a case report and literature review

C. Sánchez-Rodríguez, I. Muro, E. Casas, P. Lorenzo, C. Sanabria, A. Somovilla, L. López (Madrid, Spain)
Parkinson’s disease associated SORL1 variants impair mitochondrial and endo-lysosomal function

Z. Liu, M. Zhao, Y. Zhao, J. Tan, B. Tang (Changsha, China)
Parkinson’s disease biomarkers in human olfactory cleft mucus

J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)
Parkinson’s Disease Burden in Underserved Populations Across the US in 2022

S. Kowal, K. Rosettie, E. Mearns, N. Win, H. Lin, B. Musch (South San Francisco, USA)
Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL

E. Carr, T. Cash, C. Lessov-Schlaggar, H. Hwang, A. Eid, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)
Parkinson’s disease in a Special Population -Diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists-

M. Nomoto, S. Oda, H. Doi (Imabari, Japan)
Parkinson’s disease in Brazil: prevalence and patient characteristics in a nationwide representative population-based cohort.

D. Teixeira-Dos-Santos, G. Magalhães Pereira, G. Alves Marconi, T. Hugentobler Schlickmann, AF. Schumacher Schuh (Porto Alegre, Brazil)
Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)
Parkinson’s Disease tremor can show entrainment and distractibility with electrophysiological assessment using tapping test.

T. Grippe, N. Sheth, N. Raies, M. Callister, M. Ding, N. Desai, R. Chen (Toronto, Canada)
Parkinson’s Progression Markers Initiative (PPMI): Investigating Biomarker Driven PD Progression

B. Mcmahon, A. Siderowf, T. Simuni, C. Tanner, B. Mollenhauer, C. Coffey, D. Galasko, K. Poston, L. Chahine, R. Dobkin, T. Foroud, K. Kieburtz, D. Weintraub, K. Merchant, M. Frasier, T. Sherer, S. Chowdury, E. Brown, R. Alcalay, A. Videnovic, K. Fabrizio, E. Flagg, C. Stanley, K. Marek (Baltimore, USA)
Parkinsonism after Internal Globus Pallidus Deep Brain Stimulation in Dystonia

T. Lampreia, D. Martins, L. Guedes, M. Mendonça, M. Coelho (Loures, Portugal)
Parkinsonism Associated with Twinkle Gene Mutation

C. Felin, B. Oliveira, Y. Borges, S. Trentin (Porto Alegre, Brazil)
Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

P. Hoff, F. Butt (Oklahoma City, USA)
Parkinsonism in combined Fragile X and XYY Syndromes: A Case Report

M. Carta, B. Balint (Zurich, Switzerland)
Parkinsonism in setting of hypoparathyroidism

R. Fekete (Hawthorne, USA)
Paroxysmal non-kinesigenic dyskinesia: atypical neurological presentation of Lyme neuroborreliosis

I. Sarac, H. Sarac, F. Borovecki, Z. Kresic (Zagreb, Croatia)
Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

J. Verbrugge, H. Oas, L. Cook, T. Schwantes-An, L. Walsh, T. Foroud, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, A. Hall, A. Naito, J. Beck, R. Alcalay (Indianapolis, USA)
Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)
Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)
Pathological Mechanisms Associated with Atrazine-Induced Parkinson’s Disease Pathogenesis in Rat Model: The Rescue Role of Myricetin

C. Ikeji, E. Farombi (Ibadan, Nigeria)
Pathways for diagnosis and multimodal management, including botulinum neurotoxin therapy, in shoulder conditions following central lesions

B. Biering-Sørensen, C. Cordero-García, C. Boulias, D. Hoad, D. Bensmail, F. Molteni, F. Genêt, J. Wissel, P. Marque, S. Berweck, J. Jacinto (Glostrup, Denmark)
Patient and Caregiver Experiences with Huntington Disease: Emotions, Challenges, and Unmet Needs in the Patient Journey

A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)
Patient and Caregiver Experiences with Tardive Dyskinesia: Emotions, Challenges, and Unmet Needs in the Patient Journey

A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)
Patient Characteristics and Real-World Use of Botulinum Toxins for Treatment of Chronic Sialorrhea

M. Hast, A. Kong, J. Abdelhadi, A. Szendrey, R. Shah, J. Holmes (Raleigh, USA)
Patient Experience during Automated Deep Brain Stimulation (DBS) Changing for Sleep (PEACe study)

S. Fay, K. Au, K. Lyons, Y. Pathak, R. Pahwa (Kansas City, USA)
Patient Experiences Initiating Continuous Subcutaneous Apomorphine Infusion (CSAI): An Interview-Based Survey of InfusON Study Participants

P. Agarwal, N. Crouse, A. Breiteneicher, M. Formella (Kirkland, USA)
Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)
Patient-developed Unique Methods to Overcome Freezing of Gait in Parkinsonian Disorders

Y. Okuma (Izunokuni, Japan)
Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review

J. Saade, T. Mestre, G. Stebbins, A. van Wyk (Ottawa, Canada)
Patients with Parkinson’s disease have frequently pincer nail deformity

M. Sakamoto, H. Nagayama, K. Kimura (Tokyo, Japan)
PD GENEration: A cross-sectional evaluation of cognitive complaints in Parkinson’s disease (PD) patients according to GBA1 and DBS status

J. Son, K. Ghosh Galvelis, A. Naito, J. Beck, R. Alcalay, G. Pal (New Brunswick, USA)
PD GENEration: a genetic analysis beyond the classical 7 Parkinson’s disease genes

I. Keller Sarmiento, V. Pitz, C. Blauwendraat, Z. Fang, T. Tatiana Foroud, A. Hall, K. Marder, I. Mata, M. Nance, M. Schwarzchild, T. Simuni, A. Wills, S. Lawrence, K. Ghosh Galvelis, J. Beck, A. Naito, R. Alcalay, N. Mencacci (Chicago, USA)
PD in Tanzania: representative in city dwellers, absent in nomadic tribespeople?

S. Urasa, W. Howlett, R. Walker, M. Dekker (Moshi, United Republic of Tanzania)
PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)
PD-DigiCare: Enhancing referral decision-making for advanced treatment in Parkinson’s Disease through objective measurements and patient reported outcomes – a multicenter randomized controlled trial.

N. Karottki, T. Hørmann Thomsen, P. Jennum, M. Blaabjerg, B. Biering-Sørensen (Glostrup, Denmark)
Perceptions of Diseases in Patients with Cervical Dystonia

D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, M. Patel, M. Moreno-Escobar, A. Murray, A. Memon, J. Frey (Morgantown, USA)
Perceptions Regarding Asleep and Awake DBS Among Neurologists and Neurosurgeons

A. Tsai, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, Y. Gordeyeva, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, J. Wong, L. Verhagen Metman (Columbus, USA)
Performance of a Smartphone-based Oculomotor Test as a Diagnostic Tool for Parkinson’s Disease

C. Edwards, A. Zirra, IA. John, A. Bogucki, R. Torricelli, J. Kenny, S. Ganesh, K. Dey, T. Haque, D. Gallagher, C. Budu, C. Simonet, M. Wlodarski, J. Neffendorf, R. Chrapkiewicz, SG. Manohar, AJ. Noyce (London, United Kingdom)
Peri-Electrode Edema after Deep Brain Stimulation Implantation – Case Report and Literature Review

M. Marchiori, L. Packer, R. Pessoa, N. Martins, A. Schilling, M. Brunet (Brazil)
Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)
Peripheral immune profile and neutrophil-to-lymphocyte ratio in Progressive Supranuclear Palsy

L. Muñoz-Delgado, A. Luque-Ambrosiani, B. Benítez Zamora, D. Macías-García, S. Jesús, AD. Adarmes‐gómez, E. Ojeda-Lepe, F. Carrillo, P. Mir (Sevilla, Spain)
Peripheral immunity and clinical phenotypes in patients with ventriculomegaly

C. Espinoza-Vinces, I. Avilés-Olmos, G. Martí-Andrés, M. Jiménez-Vázquez, M. Calvo-Imirizaldu, M. Marín Gracia, R. Villino-Rodríguez, A. Atorrasagasti-Villar, J. Arbizu, MR. Luquin (PAMPLONA, Spain)
Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)
Perry Syndrome due to a DCTN1 novel variant

P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)
Personality may influence the response to apomorphine infusion in Parkinson’s disease patients

M. Boussac, E. Harroch, C. Barthelemy, F. Ory-Magne, C. Leung, M. Fabbri, C. Arbus, C. Brefel-Courbon (Toulouse, France)
Personality of Parkinson’s disease patients may influence the development and evolution of non-motor fluctuations

M. Boussac, F. Faggianelli, E. Harroch, A. Eusebio, M. Fabbri, F. Ory-Magne, E. Descamps, O. Rascol, C. Laurencin, AR. Marques, M. Anheim, B. Giordana, L. Hopes, C. Moreau, AS. Rolland, D. Devos, D. Maltete, S. Ansquer, E. Hainque, S. Drapier, JP. Brandel, T. Rouaud, D. Guehl, B. Jarraya, M. Tir, T. Witjas, JP. Azulay, C. Brefel-Courbon (Toulouse, France)
Personalized Optimization of Deep Brain Stimulation Parameters for Gait Enhancement in Parkinson’s Disease: A Data-Driven Approach

H. Fekri Azgomi, K. Louie, J. Bath, J. Balakid, J. Marks, D. Wang (San Francisco, USA)
Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms

S. Messner, T. Carmody, R. Park, B. Jones, A. Hursey, E. Lucassen (Basel, Switzerland)
Pharmacokinetic Intersections in Geriatric Neuropharmacology: A Parkinson’s Disease Case Study with Concomitant Refractory Major Depressive Disorder

D. Nolasco, L. Schmidt, B. Carr (Gainesville, USA)
Pharmacokinetic-Pharmacodynamic Modeling of Amantadine Extended-Release Capsule Effects on Dyskinesia in Parkinson Disease

Z. Wang, R. Gomeni, R. Pahwa, R. Hauser, A. Formella, M. Grall, H. Upadhyaya, J. Rubin (Rockville, USA)
Pharmacokinetics And Safety Of YA-101, A Dual Inhibitors Of D-Amino Acid Oxidase (DAAO) And NLRP3 Inflammasome, In Healthy Subjects: A Double-Blind, Placebo-Controlled, Randomized, Single Dose and Multiple Dose Phase I Study

YJ. Tseng, BH. Su, O. Lin, DZ. Luo, TF. Lo, YC. Huang, CC. Li (Taipei, Taiwan)
Pharmacokinetics of Levodopa after Subcutaneous bolus delivery of foslevodopa/foscarbidopa

YR. Han, S. Stodtmann, M. Rosebraugh (North Chicago, USA)
Pharmacological neuromodulation with intracerebroventricular administration of anaerobic dopamine for Parkinson’s disease

C. Moreau, P. Odou, A. Demailly, G. Touzet, N. Reyns, J. Labreuche, A. Duhamel, C. Barthelemy, D. Lannoy, N. Carta, B. Palas, F. Marchand, B. Gouges, C. Leclerc, C. Potey, T. Ouk, K. Dujardin, S. Baigne, L. Carton, AS. Rolland, JC. Devedjian, V. Foutel, D. Deplanque, M. Fisichella, D. Devos (Lille, France)
Phenomenology of Coenzyme Q10-deficiency Spinocerebellar Ataxia: Case Description Of Two Siblings And New Therapeutic Perspectives

S. Cartella, S. Bertino, A. Gardin, S. Neri, A. Battaglia, G. Foti, C. Terranova, G. Cartella, A. Quartarone (Reggio Calabria, Italy)
Phenomenology of Functional Movement Disorders in Children

A. Cherian, D. Kalikavil Puthanveedu (Thiruvananthapuram, India)
Phenotypic Aspects of Huntington’s Disease-Like 2 in Brazil and the World: Literature Review

D. Boone, M. Costa, C. Silva, L. Barcelos, B. Veiga, R. Pinto, P. Aguiar, S. Azevedo, V. Borges, H. Ferraz (São Paulo, Brazil)
Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)
Phenotypic spectrum and natural history of POLR3A-associated spastic ataxia

E. Jung, J. Infante, S. Satolli, F. Santorelli, M. Minnerop, S. Klebe, B. Warrenburg, J. Muñoz, A. Fellner, J. de Winter, A. O'Connor, J. Baets, S. Murphy, M. Ruiz Sales, A. Pujol Onofre, L. Ruggiero, G. Coarelli, A. Dürr, X. Kobeleva, C. Stendel, T. Klopstock, F. Nicita, E. Bertini, Q. Thomas, Y. Goldberg, E. Kogan, L. Basel-Salmon, A. Lossos, Z. Argov, A. de Munain, L. Schöls, R. Schüle (Heidelberg, Germany)
Phenotypic Variability in Combined Parkinsonism-Dystonia and Isolated Idiopathic Dystonia

S. Idrissi, A. Trinchillo, V. Velucci, R. Pellicciari, M. Esposito, D. Belvisi, G. Fabbrini, R. Erro, C. Terranova, M. Zibetti, MC. Altavista, MS. Cotelli, A. Castagna, P. Barbero, D. Cassano, MM. Mascia, T. Ercoli, L. Magistrello, T. Schirinzi, M. Tinazzi, A. Pisani, L. Marinelli, A. Berardelli, G. Defazio (Bari, Italy)
Phenotypic variability of mitochondrial tRNA Ser(UCN) gene [MTTS1] mutation: First report from India

N. Pandita, J. Ganguly, P. Basu, N. Singh, S. Mukherjee, H. Kumar (Kolkata, India)
Phenotypic Variability of PRNP and Related Movement Disorders

M. Tuesta Bernaola, J. Ganguly, M. Jog (London, Canada)
Physical activity in patients with atypical parkinsonian syndromes – Collection of real-world data

V. Sidoroff, G. Prigent, H. Moradi, S. Sapienza, F. Krismer, K. Seppi, J. Ndayisaba, F. Jagusch, H. Humer, P. Bachmann, B. Eskofier, J. Winkler, I. Teckenurg, M. Asalian, J. Klucken, A. Ionescu, D. Benninger, H. Gaßner, G. Wenning, K. Aminian, C. Raccagni (Innsruck, Austria)
Physical Activity Levels and Demographic Characteristics in Individuals with Huntington’s Disease: Insights from the ENROLL-HD Database in an Argentinian Movement Disorder Center

M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, G. Peker, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)
Pimavanserin Safety in Adult and Elderly Patients With Neuropsychiatric Symptoms Related to Neurodegenerative Disease: an Open-Label Extension Study

W. Cubała, A. Berrio, K. Chi-Burris, G. Alva, L. Chrones, S. Pathak (Gdańsk, Poland)
Pisa Syndrome as an early presenting feature of Corticobasal Ganglionic degeneration [CBGD]

M. Matta, N. Sawal, A. Prasad (Chandigarh, India)
Pitolisant as adjunct therapy for refractory restless legs syndrome

W. Ondo (Houston, USA)
PKG-Ethnicity project: An initial analysis of ethnical differences in Parkinson’s KinetoGraph (PKG) results between white and non-white ethnic groups

MA. Qamar, L. Batzu, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)
Plasma biomarkers for rapid eye movement sleep behavior disorder in Parkinson’s disease: a prospective cohort study

J. Lin, C. Li, R. Ou (Chengdu, China)
Plasma Biomarkers of Alzheimer’s Pathology Identify Prodromal Dementia with Lewy bodies

A. Delva, A. Pelletier, E. Sommerville, J. Montplaisir, J. Gagnon, G. Kollmorgen, T. Kam-Thong, T. Kustermann, V. Machado, Z. Gan-Or, R. Postuma (Montreal, Canada)
Plasma MicroRNA Expression Profiling in patients with Multiple System Atrophy and Parkinson’s Disease

R. Yadav, P. Ramaswamy, PK. Pal, R. Christopher (Bengaluru, India)
Plasma NFL predicting fatigue conversion in early Parkinson’s disease

NN. Che (Chengdu, China)
Plasma pTau181 and pTau217 Detect Amyloid Co-pathology and Have Specific Cut-offs in Lewy Body Disease

A. Smith, M. Plastini, N. Ashton, L. Montoliu-Gaya, E. Wilson, B. Arslan, C. Young, J. Winer, M. Shahid-Besanti, H. Vossler, G. Kerchner, B. Cholerton, K. Andreasson, M. Yutsis, V. Henderson, T. Montine, L. Tian, E. Mormino, H. Zetterberg, K. Poston, C. Abdelnour (Stanford, USA)
PMM2 mutation

H. Teive, J. Duarte, LE. de Farias, S. Raskin, F. Tensini, D. Amarante (Curitiba, Brazil)
Polyamine pathways: a promising frontier for biomarkers and therapeutic targets in Parkinson’s disease (PD)

W-L. Tsou, P. Lewitt, B. Ranxhi, Z. Chbihi, Z. Bangash, S. Todi (Detroit, USA)
Pooling Event-Related Potentials with Anatomy and Lead Localization in Subthalamic Deep Brain Stimulation

C. Schedlich-Teufer, E. Reise, T. Schüller, V. Visser-Vandewalle, M. Barbe, T. Dembek (Cologne, Germany)
Possible Sarcopenia and its Association with Physical Activity among Parkinson’s disease Patients

APC. Loureiro, C. Moreira, J. Monteiro, N. Dias, LF. Moreira (Curitiba, Brazil)
Post-stroke Movement Disorders: A Systematic Review of the Clinical Spectrum, Neuroanatomy, and Demographic Characteristics of 577 Published cases

B. Mishra, A. Agarwal, M. Nayak, N. Nilima, P. Srivastava, V. Vishnu (South delhi, India)
Posterior Fossa Arachnoid Cysts In Two Patients With Suspected Multiple System Atrophy – Cerebellar Type

A. Blazek, E. Flanagan, E. Coon, L. Jackson (Rochester, USA)
Postural Stability Relates to Autonomic Dysfunction in Parkinson’s Disease

A. Homagain, K. Ehgoetz Martens (Waterloo, Canada)
Pre-treatment with Methanolic Extract Mucuna pruriens Seeds Attenuates Serotonin Gene Depletion, Motor Dysfunction and Anxiogenic Responses in a Rat Model of Parkinsonism

A. Obajuluwa, B. Laoye, J. Okwuaka, T. Obajuluwa, J. Lech, A. Oremosu (Ado -Ekiti, Nigeria)
PreActive-PD Telehealth Coaching to Increase Physical Activity in Early-Stage Parkinson Disease: A Randomized Controlled Feasibility Trial

K. Long, A. Pacheco, L. Quinn, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (Walnut Creek, USA)
Precision Functional Mapping of Therapeutic Response in Task-specific Focal Dystonia

V. Nguyen, A. Meyer, J. Hudson, S. Norris, E. Gordon (St Louis, USA)
Preclinical Studies: Investigating Serum-Based Exosomal miRNAs in Prodromal Drug-Induced Parkinson’s Disease

M. Ahmad (Hyderabad, India)
Predictability of Motor States With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease

R. Hauser, M. Bouchard, D. Santos-Garcia, L. Bergmann, R. Gupta, L. Harmer, M. Shah, C. Yan, S. Isaacson (Tampa, USA)
Predicting Clinical Status of Patients with Huntington’s Disease from Raw Speech Samples, a Lightweight Machine Learning Approach

C. Le Moine, R. Massart, A-C. Bachoud-Lévi (Paris, France)
Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)
Predicting Disease Severity in Friedreich’s Ataxia through Wearable Monitoring and Machine Learning.

R. Mishra, A. Sastre, A. Enriquez, V. Profeta, M. Wells, A. Vaziri, D. Lynch (Newton, USA)
Predicting Freezing of Gait (FoG) in Parkinson’s Disease from Conventional T1-Weighted MRI

G. Rathi, A. Gardner, Z. Mari, V. Mishra (Birmingham, USA)
Predicting prodromal Parkinson’s disease with a deep learning algorithm using medical and prescription data

WW. Lee, Y. Koo, M. Kim (Seoul, Republic of Korea)
Predicting the Risk of Parkinson’s Disease by Body Composition and Metabolic Diseases in Gender and Age Dependent Manners

J. Fu, H. Shang, X. Chen (Chengdu, Sichuan, China)
Prediction of amyloid positivity in Dementia with Lewy bodies using the early-phase 18F-FP-CIT PET images

SJ. Chung, SH. Kim, PH. Lee, YH. Sohn, Y. Jeong, YJ. Kim (Yongin-si, Republic of Korea)
Prediction of falls in PD over 5 years using kinematic data and machine learning

C. Sotirakis, M. Brzezicki, S. Patel, J. Fitzgerald, N. Conway, C. Antoniades (Oxford, United Kingdom)
Prediction of The Monopolar Review in Deep Brain Stimulation for Parkinson’s Disease using Imaging

V. Lavu, M. Godhala, T. Batchali, S. Aghili-Mehrizi, J. Wong (Gainesville, USA)
Prediction of Time-to-Phenoconversion to Parkinsonism in Idiopathic REM Sleep Behavior Disorder (iRBD)

SM. Fereshtehnejad, A. Delva, Y. Zeighami, M. Dadar, A. Pelletier, J. Montplaisir, JF. Gagnon, C. Marras, R. Postuma (Toronto, Canada)
Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)
Predictive elements for unilateral prelemniscal radiations radiofrequency lesions: A novel surgical approach for alleviating motor symptoms in Parkinson’s disease

A. Armas-Salazar, J. Navarro-Olvera, F. Velasco-Campos, F. Jimenez-Ponce, G. Aguado-Carrillo, J. Beltran, J. Carrillo-Ruiz (Mexico City, Mexico)
Predictive Value of Brain Structural Changes on Motor Outcomes Following VIM Thalamotomy in Essential Tremor: Preliminary Results

Y. Samanci, A. Bayram, H. Gezegen, AH. Duzkalir, E. Sahin, B. Samanci, S. Peker (Istanbul, Turkey)
Predictors of Death within 6 Months in Individuals with Dementia with Lewy Bodies

M. Armstrong, Y. Dai, B. Labarre, H. Fechtel, K. Sovich, J. Galvin, H. Paulson, S. Maixner, C. Manning, J. Fields, A. Lunde, B. Boeve, L. Forsberg, A. Taylor, Z. Li (Gainesville, USA)
Predictors of Response to Botulinum Toxin Treatment in Patients With Hemifacial Spasm:A Prospective Study

S. Jain, S. Pandey, RK. Garg, HS. Malhotra, I. Rizvi (Lucknow, India)
Pregnancy and delivery in women with Parkinson’s disease: A case series

W. Kapelle, A. Oosterbaan, G. Patané, C. Piat, K. Ghoniem, E. Camerucci, P. Turcano, J. Bower, R. Savica (Rochester, USA)
Pregnancy in Dystonia or Tourette’s patients with DBS. Eleven New Cases and a Review of the Literature.

R. Mehanna, A. Tarakad, L. Taneff, E. Furr Stimming (Houston, USA)
Pregnancy in Parkinson’s disease: Five cases

C. Armas, Y. Núñez, G. Gushiken, C. Cosentino (Lima, Peru)
Preliminary Efficacy of Bilateral Intraputaminal Delivery of GDNF Gene Therapy (AAV2-GDNF; AB-1005) in Parkinson’s Disease: 18-Month Follow-Up From a Phase 1b Study

N. Phielipp, C. Christine, A. Merola, J. Elder, P. Larson, W. San Sebastian, M. Fiandaca, C. Urrea, M. Wisniewski, A. van Laar, A. Kells, K. Bankiewicz (Irvine, USA)
Pressure Sensor Insole Gait Assessment for Parkinson’s Disease patients: A longitudinal study.

G. Karamanis, V. Skaramagkas, I. Boura, C. Chatzaki, E. Chroni, D. Fotiadis, C. Spanaki, M. Tsiknakis, Z. Kefalopoulou (Patras, Greece)
Prevalence and characteristics of anxiety in Parkinson’s disease

I. Murasan, S. Diaconu, L. Ungureanu, I. Despa, A. Zarnoveanu, B. Opritoiu, C. Falup-Pecurariu (Brasov, Romania)
Prevalence and Spectrum of Movement Disorders in a Rural Neurology Clinic in Western India

D. Desai, S. Udani, A. Shah, S. Desai (Anand, India)
Prevalence of Advanced Parkinson’s Disease and Potential Candidacy for Device-Aided Therapies in the Casablanca Region: Preliminary Results of a Multicenter Regional Study

M. Daghi, A. Lakhdar, H. El Otmani (Casablanca, Morocco)
Prevalence of Autonomic Symptoms in Mexican Population with Parkinson’s Disease

A. Domínguez-García, A. Cervantes-Arriaga, M. Rodríguez-Violante, AJ. Hernández-Medrano, G. Rivera-Monroy, K. Velázquez-Román, AL. Guerra-Anzaldo, DP. Romero-Terán, WF. Moguel-Cardín, RJ. Baños-Betancourt, CF. álvarez-Hernández, D. Rebolledo-García (CDMX, Mexico)
Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD

H. Karkourian, L. Atabekyan, N. Nadryan, E. Balian, A. Grigoryan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)
Prevalence of Cognitive Disorders and Other Features of Parkinson’s Disease in Kyrgyz Republic

E. Eralieva, M. Moldokulova, K. Dzholboldieva (Osh, Kyrgyzstan)
Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)
Prevalence of Heterozygous ATP7B Mutation in Patients with Movement Symptoms

Y. Kim, D. Park, J. Yoon (Suwon, Republic of Korea)
Prevalence of immune-mediated diseases in long-term chelator therapy in Wilson’s Disease

C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)
Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.

N. Guragain, P. Gyawanli, A. Mudvari, P. Prasad, R. Ghimire, B. Gajurel, R. Ojha (Kathmandu, Nepal)
Prevalence of non-motor symptoms and their impact in quality of life in PD: a Mexican Registry, 2011-2019 (the ReMePark-2 study).

A. Cervantes Arriaga, AJ. Hernandez Medrano, A. Dominguez Garcia, DP. Romero Terán, MF. Medina Perez, M. Rodriguez Violante, A. Abundes Corona, R. Solis Vivanco, AL. Guerra-Anzaldo, G. Rivera-Monroy, CF. álvarez-Hernández, RJ. Baños-Betancourt, WF. Moguel Cardín ()
Prevalence of Non-Motor Symptoms in Patients with Parkinson Disease in a Tertiary Hospital in Santiago, Chile.

M. Sánchez, V. Rosado, C. Montalva, P. Salles, J. Fuentes, P. Chaná (Santiago, Chile)
Prevalence of Parkinson’s Disease and Possible Parkinsonian Syndrome in Gaucher Disease: Data From the ICGG Gaucher Registry

R. Alcalay, P. Mistry, A. Di Fonzo, J. Batista, P. Bianculli, J. Carwile, G. Perichon, M. Balwani (New York, USA)
Prevalence of Phosphorylated Alpha-Synuclein in Skin Biopsies of Essential Tremor Patients

S. Bellows, N. Vanegas Arroyave, J. Jankovic (Housont, USA)
Prevalence of Tic Disorder in School Children of Northern India

S. Lavania, A. Pattojoshi, AH. Khan (Agra, India)
PREVENT-PD: A Framework for Collecting Trichloroethylene Contamination Data in New York State

M. Pawlik, K. Hylton, S. Hussain, M. Piraino, D. Kinel, R. Dorsey (Rochester, USA)
Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention

C. Piccinin, J. Yu, A. Brooks, V. Stepanyants, P. Clark, S. Shaffer, B. Sokola, K. Lewin, C. Sonneborn, O. Hogue, S. Sperling, H. Fernandez, W. Walter (Cleveland, USA)
Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy

T. Kojiri, N. Nishikawa, Y. Uchida, M. Nozaki, N. Yoshihara, S. Ueno, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)
ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment

R. Scherbaum, E. Hinrichs, A. Horstmann, J. Schmidt-Fleischer, J. Stein, J. Geritz, J. Welzel, E. Kwon, J. Oppermann, V. Tschentscher, A. Mattukat, S. Muhlack, S. Faissner, C. Hansen, K. Winklhofer, R. Gold, W. Maetzler, N. Timmesfeld, L. Tönges (Bochum, Germany)
Prodromal and overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): preliminary results

L. Pedrosa, J. Duarte, G. Pereira, I. Oliveira, S. Titze-de-Almeida, A. Schuh, C. Rieder, G. Valença, P. Brandão, L. Krejcová, B. Santos-Lobato (Belém, Brazil)
Prodromal Parkinson’s disease in the general population

G. de Klerk, T. van Laar, S. Meles (Groningen, Netherlands)
Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)
Profile of patients affected by movement disorders in subspecialized outpatient clinics of a tertiary hospital in Southern Brazil

D. Teixeira-Dos-Santos, G. Magalhães Pereira, T. de Carvalho, P. Ribeiro Rigo, J. Käfer Pasin, I. Fonseca Benati, E. Drews Amorim, M. Testa-da-Silva, T. Lampert Monte, BS. de Oliveira, R. Machado Castilhos, AF. Schumacher Schuh (Porto Alegre, Brazil)
Prognostic role of postganglionic cardiovascular dysfunction in Multiple System Atrophy

R. Telese, A. Elia, R. Cilia, F. Colucci, V. Leta, A. Braccia, L. Romito, R. Eleopra, G. Devigili (Milan, Italy)
Prognostic Value of Parkinson’s Disease Subtypes in the LABS-PD Cohort: Functional ability, Quality of life and Mortality

D. Dash, S. Eberly, D. Oakes, D. Grimes, A. Lang, C. Tanner, C. Marras, T. Mestre (Ottawa, Canada)
Programming Adaptive Deep Brain Stimulation in the Clinic: Lessons from the ADAPT-PD Trial

T. Herrington, M. Beudel, J. Ostrem, S. Little, L. Almeida, A. Ramirez-Zamora, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, S. Stanslaski, L. Tonder, Y. Tan, R. Summers, T. Goble, R. Raike, H. Bronte-Stewart (Boston, USA)
Progression of motor asymmetry in the MDS-UPDRS III in Parkinson’s Disease with and without REM Sleep Behavior Disorder over five years

S. Elasfar, H. Hameed, K. Ehgoetz-Martens (Waterloo, Canada)
Progressive Apraxia of Speech as a Presenting Symptom of Spinocerebellar Ataxia Type 2

A. Blazek, G. Meade, L. Jackson, R. Gavrilova, J. Stierwalt, J. Martinez-Thompson, J. Duffy, H. Clark, M. Machulda, J. Whitwell, K. Josephs, R. Utianski, H. Botha (Rochester, USA)
Progressive Cerebellar Ataxia as the Predominant Symptomatology of SGP-7 Compound Heterozygote Pathogenic Variants related HSP-7

D. Menghani, T. Yamasaki (Nicholasville, USA)
Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report

T. Nguyen, V. Le, K. Vo, T. Tran (Ho Chi Minh, Viet Nam)
Progressive freezing of gait in atypical parkinsonism. A Possible Progressive Supranuclear Palsy phenotype.

H. Pacheco Mendoza, L. Nuñez Orozco, A. Negrete Gomez, J. Delgado Uriarte, C. Gómez Rubio (Mexico, Mexico)
Progressive Myoclonic Ataxia: Neuroinflammation and Autoantibodies Against Inhibitory Synapses and Herpes Viruses

D. Labunskiy, S. Kiryukhina, N. Kurgaev, V. Podsevatkin, V. Kolmykov (Saransk, Russian Federation)
Prokineticin-2 is highly expressed in colonic mucosa of early Parkinson’s disease patients

G. Bellini, G. Palermo, F. Rettura, E. Del Prete, E. Unti, C. Ippolito, C. Pellegrini, D. Frosini, N. Bernardini, R. Ceravolo (Pisa, Italy)
Prolonged Positive Response: Subthalamic Nucleus as a Deep Brain Stimulation Target in X-linked Dystonia-Parkinsonism

I. Khatiwala, P. Moondra, A. Azurin, B. Kopell, J. Jimenez Shahed, W. Tse (New York, USA)
Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression

S. Shin, K. Ho, C. Chen, S. Li, N. Kowahl, E. Rainaldi, L. Evers, M. Meinders, L. Shih, A. Siderowf, B. Bloem, R. Kapur (South San Francisco, USA)
Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)
Prospective Study of Gait and Multimodal MRI Biomarkers for Multiple System Atrophy

F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, D. Guehl, G. Kuchcinski, C. Moreau (LILLE, France)
Protocol for Cerebellar Deep Brain Stimulation in Children and Young Adults with Dyskinetic Cerebral Palsy: Combined N-of-1 trials to Assess Safety and Efficacy

A. Wiltshire, M. San Luciano, C. Oehrn, S. Wang, J. Tolmie, R. Graff, J. Zhu, P. Starr (San Francisco, USA)
PSP-Like Syndrome Associated with Dysautonomic Findings as a Presentation of an Anti-Iglon5 Antibody-Related Encephalopathy

A. Gomez, MB. Charra Castellani, F. Knorre, D. Ballesteros, V. Kurtz (Buenos Aires, Argentina)
PSP: a Clinical Case

K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)
Psychotic features in patients with Parkinson’s disease

S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)
Pulmonary Dysfunction in Friedreich’s Ataxia (FRDA)

T. Zesiewicz, T. Vu, A. Patel, T. Mcdonald, Y. Huang, Y. Zhao, L. Campbell, L. Evans, D. Mohan, C. Gooch, K. Calero (Tampa, USA)
Pump Priming a Parkinson’s Rapid Response Physiotherapy and Occupational Therapy Service

F. Lindop, R. Skelly, B. Denney, S. Voyce (Derby, United Kingdom)
Pure Autonomic Failure As a Severe “Body-First Subtype” of Lewy Body Disease: A Multimodal Imaging Study of the Autonomic Nervous System

C. Skjaerbaek, I. Cani, K. Knudsen, G. Carrozzo, P. Guaraldi, T. Lillethorup, T. Fedorova, A. Terkelsen, P. Cortelli, P. Borghammer (Aarhus, Denmark)
Putaminal dopamine modulates movement motivation in Parkinson’s disease

M. Banwinkler, V. Dzialas, L. Rigoux, H. Theis, A. Asendorf, K. Giehl, M. Tittgemeyer, M. Hoenig, T. van Eimeren (Cologne, Germany)